As part of their agreements with CMS, the manufacturers must demonstrate how these lifestyle support programs will meet the program requirements, including encouraging healthy eating and increasing physical activity, supporting medication adherence, ensuring engagement with the program on a regular basis, and ensuring availability of this program to all patients receiving these medications, either online or offline for those who have limited digital access
There is rising demand for the drug, after the US manufacturer Eli Lilly announced a major price increase from 1 September
If you are taking a GLP-1 for weight loss, Medicaid typically wont cover it
Each dose corresponds to a specific pen or vial configuration, and errors, while rare, can happen
Chen, W., Cai, P., Zou, W
If youre interested in weight loss medications, talk with your healthcare provider about what options might work for you now, and keep retatrutide on your radar as it moves through the approval process